|
|
 |
 |
Search Results for: N |
 |
|
 |
|
|
 |
| 31 |
N-(3-Chloropropyl)morpholine
Manus Aktteva offers Gefitinib Intermediate, N-(3-Chloropropyl)morpholine,7357-67-7, for your evaluation,pilots and commercial requirements with supportive technical package required for evaluation
View Detail
|
 |
|
|
| 32 |
N-(4-Chlorophenyl)-2,2-dimethylpropanamide
Manus Aktteva can offer N-(4-Chlorophenyl)-2,2-dimethylpropanamide, 65854-91-3 for your evaluation, pilots and commercial requirements with supportive technical package required for evaluation
View Detail
|
 |
|
|
| 33 |
N-(5-amino-2-methylphenl)-4-(3-pyridyl)-2-pyrimidine-amine
Manus Aktteva offers Imatinib Intermediate, N-(5-amino-2-methylphenl)-4-(3-pyridyl)-2-pyrimidine-amine, 152460-10-1, for your evaluation, pilots and commercial requirements with supportive technical package required for evaluation.
View Detail
|
 |
|
|
| 34 |
N-[(1S)-1-benzyl-2-({(1R)-3-methyl-1-[(1S,2S,6R,8S)-2,9,9-trimethyl-3,5-dioxa-4-boratricyclo[6.1.1.0~2,6~]dec-4-yl]butyl}amino)-2-oxoethyl]-2-pyrazinecarboxamide
Manus Aktteva offers Bortezomib Intermediate, N-[(1S)-1-benzyl-2-({(1R)-3-methyl-1-[(1S,2S,6R,8S)-2,9,9-trimethyl-3,5-dioxa-4-boratricyclo[6.1.1.0~2,6~]dec-4-yl]butyl}amino)-2-oxoethyl]-2-pyrazinecarboxamide, 205393-22-2, for your evaluation, pilots ....
View Detail
|
 |
|
|
| 35 |
N-[(1S)-2-[(1S,3S,5S)-3-Cyano-2-azabicyclo[3.1.0]hex-2-yl]-1-(3-hydroxytricyclo[3.3.1.13,7]dec-1-yl)-2-oxoethyl]carbamic acid 1,1-dimethylethyl ester
Manus Aktteva offers Saxagliptin Intermediate,709031-43-6, N-[(1S)-2-[(1S,3S,5S)-3-Cyano-2-azabicyclo[3.1.0]hex-2-yl]-1-(3-hydroxytricyclo[3.3.1.13,7]dec-1-yl)-2-oxoethyl]carbamic acid 1,1-dimethylethyl ester,for your evaluation,pilots and commercial....
View Detail
|
 |
|
|
| 36 |
N-[(2'-Cyano-(1,1'-biphenyl)-4-yl)methyl)]valine methyl ester
Manus Aktteva offers Intermediate of Valsartan, N-[(2'-Cyano-(1,1'-biphenyl)-4-yl)methyl)]valinemethyl ester, 137863-89-9,for your requirements of RND, evaluation, pilots and commercial along with supportive technical package required for evaluation ....
View Detail
|
 |
|
|
| 37 |
N-[[4-(2-dimethylaminoethoxy)phenyl]methyl]-3,4-dimethoxy-benzamide, Itopride
Manus Aktteva offers Itopride intermediate, 122898-67-3,for your requirements of RND, evaluation, pilots and commercial along with supportive technical package required for evaluation for intermediates.
View Detail
|
 |
|
|
| 38 |
N-[2-(2-Methoxy phenoxy) ethyl] benzyl amine
Manus Aktteva offers Carvedilol Intermediate, N-[2-(2-Methoxy phenoxy) ethyl] benzyl amine, 3246-03-5, for your evaluation,pilots and commercial requirements with supportive technical package required for evaluation.
View Detail
|
 |
|
|
| 39 |
N-[2-(2-Methoxy phenoxy) ethyl] benzyl amine Hydrochloride
Manus Aktteva offers Carvedilol Intermediate, N-[2-(2-Methoxy phenoxy) ethyl] benzyl amine Hydrochloride, 120606-08-8, for your evaluation,pilots and commercial requirements with supportive technical package required for evaluation.
View Detail
|
 |
|
|
| 40 |
N-[2-(Diethylamino)ethyl]-2,4-dimethyl-1H-pyrrole-3-Carboxamide
Manus Aktteva offers Sunitinib intermediate, N-[2-(Diethylamino)ethyl]-2,4-dimethyl-1H-pyrrole-3-Carboxamide, 590424-05-8, for RND for your evaluation, pilots and commercial requirements with supportive technical package required for evaluation
View Detail
|
 |
|
|
| 41 |
N-[3-[3-Dimethylamino-1-oxo-2-prophenyl]phenyl]acetamide
Manus Aktteva offers Intermediate of Zaleplon, N-[3-[3-Dimethylamino-1-oxo-2-prophenyl]phenyl]acetamide,96605-61-7, for your requirements of RND, evaluation, pilots and commercials along with supportive technical package required for evaluation for i....
View Detail
|
 |
|
|
| 42 |
N-[4-[(7-Chloro-2,3,4,5-tetrahydro-5-oxo-1H-1-benzazepin-1-yl)carbonyl]-3-methylphenyl]-2-methylbenzamide
Manus Aktteva offers Tolvaptan intermediate,137973-76-3, N-[4-[(7-Chloro-2,3,4,5-tetrahydro-5-oxo-1H-1-benzazepin-1-yl)carbonyl]-3-methylphenyl]-2-methylbenzamide, for your evaluation,pilots and commercial requirements with supportive technical packa....
View Detail
|
 |
|
|
| 43 |
N-[4-Cyano-3-(trifluoromethyl)phenyl]methacrylamide epoxide
Manus Aktteva offers Bicalutamide Intermediate,N-[4-Cyano-3-(trifluoromethyl)phenyl]methacrylamide epoxide,90357-51-0, for your evaluation,pilots and commercial requirements with supportive technical package required for evaluation.
View Detail
|
 |
|
|
| 44 |
N-{3-chloro-4-[(3-fluorobenzyl)oxy]phenyl}-6-iodoquinazolin-4-amine
Manus Aktteva offers Lapatinib Intermediate, N-{3-chloro-4-[(3-fluorobenzyl)oxy]phenyl}-6-iodoquinazolin-4-amine, 231278-20-9, for your evaluation, pilots and commercial requirements with supportive technical package required for evaluation.
View Detail
|
 |
|
|
| 45 |
N-3 Intermediate of Fondaparinux Sodium
Manus Aktteva offers Fondaparinux Sodium's n-3 Intermediate, MethylO-(2-azido-3,4-di-O-benzyl-2-deoxy-a-D-glucopyranosyl)-(1-4)-O-(2,3-di-Obenzyl-ß-D-glucopyranosyluronicacid)-(1-4)-O-(2-azido-2-deoxy-a-D-glucopyranosyl)-(1-4)-O-(3-O-benzyl-a-L-idopy....
View Detail
|
 |
|
|
|
|
|
|
|
 |
NOTE:
- Manus Aktteva, India is successfully representing suppliers, manufacturers from INDIA, suppliers, manufacturers from CHINA, and fulfilling the requirements of buyers from EUROPE, USA, South America, Japan, Korea, Taiwan, Australia, & middle-east.
Keywords: New Molecules, patents, R&D, cas, cas number, product, supplier, suppliers, vendor, vendors, price, prices, api, apis, active pharmaceutical ingredient, ingredients, importer, exporter, distributor, import, export, sale, producer, manufacturer, synthesizer, synthesis, gmp, cgmp, fda, dmf, cgmp, cos, inventory, stock, prompt shipment, compounding, compound, research, development, patent, r and d, pharma
- Please note that products falling in to controlled substance category shall be exported directly from the manufacturer principals only against receipt of original import permission issued by concerned authorities of the importing country.
Product enquiries may please be sent to info@manusaktteva.in, udeetjbanker@gmail.com, jdbanker@gmail.com
PATENTS:
- => Products protected by valid patents are not offered for sale in countries where the sale of such products constitutes a patent infringement and its liability is at buyer's risk.
=> Products currently covered by valid US Patents are offered for R&D use in accordance with 35 USC 271 +A13(1)
|
|
|
|
|